Inquiry Basket
Fmoc-Ala-Ala-PAB is a cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs).
| Catalog Number | Size | Price | Quantity | ||
|---|---|---|---|---|---|
| BADC-01698 | -- | $-- | Inquiry |
Fmoc-Ala-Ala-PAB is an innovative cleavable linker commonly utilized in the creation of antibody-drug conjugates (ADCs), a class of targeted cancer therapies designed to deliver cytotoxic agents specifically to cancer cells while sparing healthy tissue. This linker is a compound structure consisting of a fluorenylmethyloxycarbonyl (Fmoc) group and an alanine-alanine (Ala-Ala) dipeptide spacer connected to a para-aminobenzyloxycarbonyl (PAB) moiety. Its carefully engineered structure allows for precise drug release in response to specific intracellular conditions, which is critical for reducing systemic toxicity and improving therapeutic efficacy. The Fmoc group offers facile removal and modification properties crucial during the synthesis phase, enabling better manipulation and integration of the linker into larger molecular frameworks.
The mechanism by which Fmoc-Ala-Ala-PAB operates is primarily through enzymatic cleavage within the cellular environment. Upon the ADC’s internalization into the target cancer cell, specific intracellular enzymes, such as cathepsins, recognize and cleave the Ala-Ala portion. This cleavage prompts the subsequent degradation of the PAB moiety, facilitating the release of the attached cytotoxic drug. This enzyme-triggered release mechanism ensures that the drug is only activated in the presence of its intended target, thereby maintaining a high therapeutic index and minimizing collateral damage to healthy cells. This specificity is vital in oncological applications where selective targeting can significantly affect treatment outcomes.
In drug discovery and development, Fmoc-Ala-Ala-PAB is pivotal due to its adaptability and efficiency. Its utilization allows for the synthesis of ADCs with improved pharmacokinetic and pharmacodynamic profiles. By employing this linker, researchers can create more versatile therapeutic agents capable of targeting a wide range of tumor antigens. Moreover, the modular nature of Fmoc-Ala-Ala-PAB offers significant advantages in adjusting linker-drug ratios and chemically modifying payloads to meet diverse therapeutic needs. This adaptability not only enhances the drug’s targeting efficiency but also provides pathways for overcoming resistance mechanisms that often arise during cancer treatments.
The importance of Fmoc-Ala-Ala-PAB in targeted drug delivery extends beyond its primary use in ADCs. It serves as a model for developing other cleavable linkers that can respond to varying physiological triggers within the body. Its design principles have informed the creation of linkers that respond to different biological stimuli, such as pH changes and redox conditions, which are key features of the tumor microenvironment. Through these innovations, Fmoc-Ala-Ala-PAB helps pave the way for more advanced drug delivery systems, impacting new therapies for various diseases including autoimmune disorders and infectious diseases.
Customer Support
Providing excellent 24/7 customer service and support
Project Management
Offering 100% high-quality services at all stages
Quality Assurance
Ensuring the quality and reliability of products or services
Global Delivery
Ensuring timely delivery of products worldwide
BOC Sciences offers comprehensive services for ADC manufacturing, including antibody modification, linker chemistry, payload conjugation, and formulation development. In particular, our payload-linker customization service offers a convenient and fast raw material channel for many ADC researchers.
BOC Sciences provides one-stop site-specific conjugation services for amino acids, glycans, unnatural amino acids, and short peptide tags. In addition, cysteine conjugation, lysine conjugation, enzymatic conjugation, thio-engineered antibody can also be obtained quickly.
BOC Sciences offers a full range of linkers, including peptide linkers, PEG linkers, click chemistry, PROTAC linkers, non-cleavable linkers, etc. We also provide custom development services for chemically labile linkers and enzymatically cleavable linkers.
